Docetaxel trihydrate
CAS No. | 148408-66-6 | Cat. No. | BCP01512 |
Name | Docetaxel trihydrate | ||
Synonyms | RP56976 Trihydrate;RP-56976 Trihydrate;RP 56976 Trihydrate; | ||
Formula | C43H53NO14.3(H2O) | M. Wt | 861.94 |
Description | Docetaxel trihydrate is the trihydrate form of docetaxel.Docetaxel is an antineoplastic agent that has a unique mechanism of action as an inhibitor of cellular mitosis and that currently plays a central role in the therapy of many solid tumor including breast and lung cancer. Therapy with docetaxel has been associated with a low rate of serum enzyme elevations and rarely to instances of acute hepatic necrosis generally due to severe hypersensitivity reactions or sepsis. Docetaxel has not been clearly linked to cases of idiopathic, clinically apparent acute liver injury. | ||
Pathways | Cell Cycle/DNA Damage | ||
Targets | Microtubule |
Structure

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.